公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | New therapy with ASC-J9? to suppress the prostatitis via altering the cytokine CCL2 signals | Lin S.-J.; Chou F.-J.; Lin C.-Y.; HONG-CHIANG CHANG ; Yeh S.; Chang C. | Oncotarget | 7 | 6 | |
2004 | Sale of monopoly information and behavior of rivaling clients: A theoretical perspective | Chang C.-H.; Prakash A.J.; Yeh S.; SHU YEH | Review of Financial Economics | 0 | 0 | |
2012 | The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells | Xu D.; Lin T.-H.; Zhang C.; YU-CHIEH TSAI ; Li S.; Zhang J.; Yin M.; Yeh S.; Chang C. | Prostate | 19 | 18 | |
1999 | Suppression of Δ5-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells | HONG-CHIANG CHANG ; Miyamoto H.; Marwah P.; Lardy H.; Yeh S.; Huang K.E.; Chang C. | Proceedings of the National Academy of Sciences of the United States of America | 37 | 33 | |
2009 | Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells | Altuwaijri S.; Chuang K.-H.; Lai K.-P.; Lai J.-J.; Lin H.-Y.; Young F.M.; Bottaro A.; Tsai M.-Y.; Zeng W.-P.; HONG-CHIANG CHANG ; Yeh S.; Chang C. | Molecular Endocrinology | 56 | 53 | |
2005 | Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway | Ni J.; Wen X.; Yao J.; HONG-CHIANG CHANG ; Yin Y.; Zhang M.; Xie S.; Chen M.; Simons B.; Chang P.; Di Sant'Agnese A.; Messing E.M.; Yeh S. | Cancer Research | 84 | 83 | |
2002 | The valuation implications of employee stock option accounting for profitable computer software firms | Bell T.B.; Landsman W.R.; Miller B.L.; Yeh S.; SHU YEH | Accounting Review | 70 | 62 |